Press Releases

New Patent Issued in Japan (Patent No. 7752369) Expanding CRISPR-Cas3 Patent Portfolio Posted on: October 16, 2025 Author: C4U Corporation

BioSpring Enters Strategic Partnership with Luxna Biotech to Offer Manufacture of Oligonucleotides with Luxna´s advanced XNA Amidites Posted on: October 9, 2025 Author: Luxna Biotech

CRISPR-Cas3 Basic Patent Issued in the United States (Patent No. 12371713) Posted on: September 11, 2025 Author: C4U Corporation

CRISPR-Cas3 Basic Patent Issued in Japan (Patent No. 7731156) Posted on: August 28, 2025 Author: Ｃ４Ｕ株式会社

CRISPR-Cas3 Basic Patent Issued in China (Patent No. ZL 2020 8 0025993.1) Posted on: July 30, 2025 Author: C4U Corporation

C4U and Minaris Announce Collaboration in Promotional Activities Posted on: July 14, 2025 Author: C4U Corporation

C4U Secures up to $14M non-dilutive Grant from AMED Posted on: June 6, 2025 Author: C4U Corporation

FRONTEO and Eisai launch co-creation project for target discovery using Drug Discovery AI Factory Posted on: January 28, 2025 Author: FRONTEO

Publication of White Paper on innovative drug discovery approach using Springer Nature’s literature data and FRONTEO’s specialized AI engine KIBIT Posted on: January 16, 2025 Author: 株式会社FRONTEO

FRONTEO and Maruishi Pharmaceutical launch co-creation project for biomarker discovery using Drug Discovery AI Factory Posted on: January 9, 2025 Author: 株式会社FRONTEO

C4U and iXgene Execute a Collaborative Research Agreement Author: C4U Corporation

UBE and FRONTEO launch co-creation project for drug repositioning using Drug Discovery AI Factory Posted on: November 15, 2024 Author: 株式会社FRONTEO